 Connection
Hitoshi Irabu to Treatment Outcome
This is a "connection" page, showing publications Hitoshi Irabu has written about Treatment Outcome.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.129 |
|
|
|
-
Shimizu M, Tada N, Irabu H, Murakoshi M, Udagawa T. Successful treatment of intractable edema with Goreisan in severe lupus nephritis with nephrotic syndrome: a case report. CEN Case Rep. 2026 Feb 05; 15(2):45.
Score: 0.020
-
Shimbo A, Kaneko S, Irabu H, Akutsu Y, Hayashi Y, Mouri M, Yamazaki S, Mori M, Shimizu M. Efficacy of hydroxychloroquine treatment for the skin manifestations of juvenile dermatomyositis. Mod Rheumatol Case Rep. 2025 07 25; 9(2).
Score: 0.020
-
Shmizu M, Kaneko S, Shimbo A, Hatano M, Miyaoka F, Irabu H, Akutsu Y, Hayashi Y, Akamine K, Mori M. Anifrolumab for refractory cutaneous lupus lesions in pediatric systemic lupus erythematosus. Lupus. 2025 Apr; 34(5):533-536.
Score: 0.019
-
Nishimura K, Ishikawa T, Okamoto N, Akamine K, Inoue N, Irabu H, Kato K, Keino H, Kojima M, Kubo H, Maruyama K, Mizuta M, Shabana K, Shimizu M, Sugita Y, Takakuwa Y, Takanashi S, Takase H, Umebayashi H, Umezawa N, Yamanishi S, Yamazaki K, Yashiro M, Yasumi T, Mori M. Efficacy and safety of abatacept for systemic juvenile idiopathic arthritis: A systematic review. Mod Rheumatol. 2024 Dec 25; 35(1):167-173.
Score: 0.019
-
Ishikawa T, Nishimura K, Okamoto N, Akamine K, Inoue N, Irabu H, Kato K, Keino H, Kojima M, Kubo H, Maruyama K, Mizuta M, Shabana K, Shimizu M, Sugita Y, Takakuwa Y, Takanashi S, Takase H, Umebayashi H, Umezawa N, Yamanishi S, Yamazaki K, Yashiro M, Yasumi T, Mori M. Efficacy and safety of tumor necrosis factor inhibitors for systemic juvenile idiopathic arthritis: A systematic review. Mod Rheumatol. 2024 Dec 25; 35(1):174-184.
Score: 0.019
-
Yamazaki S, Shimizu M, Yakabe A, Inage E, Jimbo K, Suzuki M, Miyaoka F, Kaneko S, Irabu H, Shimbo A, Ohtomo Y, Mori M, Morio T, Shimizu T. Successful treatment with tofacitinib for anti-melanoma differentiation-associated gene 5 antibody-positive juvenile dermatomyositis: case reports and review of the literature. Immunol Med. 2024 Jun; 47(2):110-117.
Score: 0.018
-
Shimizu M, Inoue N, Mizuta M, Irabu H, Okajima M, Honda Y, Nihira H, Izawa K, Yachie A, Wada T. Successful treatment of spondyloenchondrodysplasia with baricitinib. Rheumatology (Oxford). 2021 02 01; 60(2):e44-e46.
Score: 0.014
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|